# David Carey

> David Carey is the Chief Executive Officer of Preceptis Medical, the Golden Valley, Minnesota company behind the Hummingbird Tympanostomy Tube System, an FDA-cleared device that lets clinicians place pediatric ear tubes in the office without general anesthesia. Appointed CEO in July 2025, Carey brings three decades of commercial leadership across the medical device industry, including senior roles at Pristine Surgical, Stryker, Medtronic, and Invuity, where he helped guide the company through an IPO before its acquisition by Stryker. At Preceptis, he is focused on scaling the Hummingbird device to more surgeons and families nationwide.

- **Role:** Chief Executive Officer at Preceptis Medical
- **Organizations:** Preceptis Medical, Pristine Surgical, Stryker, Medtronic, Invuity
- **Nationality:** American
- **Education:** Bachelor of Arts, SUNY Geneseo, MBA, University of Rochester
- **Known for:** Appointed CEO of Preceptis Medical in July 2025 to lead the next phase of growth for the Hummingbird device., Served as VP of Sales and Marketing for Invuity, helping guide the company through a successful IPO before its acquisition by Stryker., Led Stryker's New England business as General Manager.

## Career timeline

- **2003** — Director of Marketing at Medtronic
- **2005** — Director of Sales - CRM at Medtronic
- **2015** — General Manager, Stryker New England
- **2021** — Chief Commercial Officer at Pristine Surgical
- **2025** — Appointed Chief Executive Officer of Preceptis Medical

## Achievements

- Appointed CEO of Preceptis Medical in July 2025 to lead the next phase of growth for the Hummingbird device.
- Served as VP of Sales and Marketing for Invuity, helping guide the company through a successful IPO before its acquisition by Stryker.
- Led Stryker's New England business as General Manager.
- Held senior sales and marketing leadership roles at Medtronic and Stryker across three decades in medical devices.
- Selected AcuityMD as the technology cornerstone of Preceptis Medical's Hummingbird Catalyst market-access program.

## Latest updates

- **2025-07** — Appointed Chief Executive Officer of Preceptis Medical to lead the company's next phase of strategic growth.
- **2025-10** — Announced selection of AcuityMD as the technology platform anchoring the Hummingbird Catalyst market-access program.

## Links

- Website: https://hummingbirdeartubes.com
- LinkedIn: http://www.linkedin.com/in/david-carey-1a1223

---

Profile page: https://yespress.io/david-carey
Published by YesPress — https://yespress.io
Last updated: 2026-07-20